Enhanced DNA damage response through RAD50 in triple negative breast cancer resistant and cancer stem‐like cells contributes to chemoresistance-Reference-Cited by-同舟云学术

Enhanced DNA damage response through RAD50 in triple negative breast cancer resistant and cancer stem‐like cells contributes to chemoresistance

Published:2020-11-03 Issue:7 Volume:288 Page:2184-2202
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Abad Etna¹²^ORCID,Civit Laia¹,Potesil David³,Zdrahal Zbynek³⁴,Lyakhovich Alex¹⁵^ORCID

Affiliation:

1. Vall d'Hebron Research Institute (VHIR) Barcelona Spain

2. Department of Experimental and Health Sciences Universitat Pompeu Fabra Barcelona Spain

3. Research Group Proteomics CEITEC – Central European Institute of Technology Masaryk University Brno Czech Republic

4. Institute of Molecular Biology and Biophysics Federal Research Center of Fundamental and Translational Medicine Novosibirsk Russia

5. National Centre for Biomolecular Research Faculty of Science Masaryk University Brno Czech Republic

Funder

Instituto de Salud Carlos III

Grantová Agentura České Republiky

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.15588

Reference47 articles.

1. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

2. Unravelling cancer stem cell potential

3. Cancer stem cells and chemoresistance: The smartest survives the raid

4. Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer

5. Chemoresistance is associated with cancer stem cell‐like properties and epithelial‐to‐mesenchymal transition in pancreatic cancer cells;Izumiya M;Anticancer Res,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting DNA damage repair mechanism by using RAD50-silencing siRNA nanoparticles to enhance radiotherapy in triple negative breast cancer;Materials Today Bio;2024-10

2. Super-enhancer omics in stem cell;Molecular Cancer;2024-08-01

3. Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis via Binding RAD50;Current Cancer Drug Targets;2024-04

4. Role of DNA Damage Response in Cancer and Healthy Stem Cells: Genome Stability, Tumor Development and Drug Resistance;Comprehensive Hematology and Stem Cell Research;2024

5. DNA damage response and neoantigens: A favorable target for triple-negative breast cancer immunotherapy and vaccine development;International Review of Cell and Molecular Biology;2024